Growth Metrics

CorMedix (CRMD) Total Current Liabilities (2016 - 2025)

CorMedix (CRMD) has disclosed Total Current Liabilities for 13 consecutive years, with $174.3 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities rose 414.98% to $174.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $174.3 million through Dec 2025, up 414.98% year-over-year, with the annual reading at $174.3 million for FY2025, 414.98% up from the prior year.
  • Total Current Liabilities hit $174.3 million in Q4 2025 for CorMedix, up from $133.6 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $174.3 million in Q4 2025 to a low of $3.0 million in Q1 2021.
  • Historically, Total Current Liabilities has averaged $26.5 million across 5 years, with a median of $7.4 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: plummeted 47.46% in 2021 and later surged 623.14% in 2025.
  • Year by year, Total Current Liabilities stood at $5.3 million in 2021, then rose by 18.07% to $6.3 million in 2022, then rose by 21.55% to $7.7 million in 2023, then soared by 341.15% to $33.8 million in 2024, then surged by 414.98% to $174.3 million in 2025.
  • Business Quant data shows Total Current Liabilities for CRMD at $174.3 million in Q4 2025, $133.6 million in Q3 2025, and $31.7 million in Q2 2025.